Yes they are but its a tech stock - so volatility is normal as well. I think the underlying concern is that debt will get more expensive to service in future with AUD and yield headwinds. Having said that there have been no changes with major shareholders, perhaps like myself are waiting to see how AGM transpire or perhaps major shareholders are sitting tight because they already know.
Yield rally is not assisting APX customers like Siemens have a 4x debt pile to service where many may view in cut back to A.I expenditure . But this is all conjecture and not based on any fact.
I am not worried, will continue to dollar cost average and go big around $10 if market decides to retrace hard (its in a pathetic bubble, so it should). Despite headwinds it's still growing 25%. The way I see it if EBITDA is forecasted to increase by 30% in CY21 and EV/EBITDA is 16.5% then it's in a good spot. EPS is still forecasted to increase on median despite all the downgrades 15%. If it has a P/E in the mid teens in 12 months so be it. I am ready.... if it doesn't that justifies paying a premium for quality.
APX Charts, page-1666
-
- There are more pages in this discussion • 2,207 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APX (ASX) to my watchlist
|
|||||
Last
50.0¢ |
Change
-0.005(0.99%) |
Mkt cap ! $111.5M |
Open | High | Low | Value | Volume |
51.0¢ | 53.0¢ | 49.0¢ | $1.034M | 2.032M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 25178 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.0¢ | 26979 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 25178 | 0.500 |
4 | 52371 | 0.495 |
15 | 360117 | 0.490 |
7 | 101980 | 0.485 |
10 | 470902 | 0.480 |
Price($) | Vol. | No. |
---|---|---|
0.510 | 26979 | 3 |
0.515 | 15117 | 2 |
0.520 | 73197 | 6 |
0.525 | 20811 | 2 |
0.530 | 140339 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
APX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online